These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7916994)

  • 1. Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2.
    Macé K; Gonzalez FJ; McConnell IR; Garner RC; Avanti O; Harris CC; Pfeifer AM
    Mol Carcinog; 1994 Oct; 11(2):65-73. PubMed ID: 7916994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4.
    Van Vleet TR; Macé K; Coulombe RA
    Cancer Res; 2002 Jan; 62(1):105-12. PubMed ID: 11782366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and cytotoxicity of aflatoxin b1 in cytochrome p-450-expressing human lung cells.
    Van Vleet TR; Klein PJ; Coulombe RA
    J Toxicol Environ Health A; 2002 Jun; 65(12):853-67. PubMed ID: 12079611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
    Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
    Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 2A13 enhances the sensitivity of human bronchial epithelial cells to aflatoxin B1-induced DNA damage.
    Yang X; Zhang Z; Wang X; Wang Y; Zhang X; Lu H; Wang SL
    Toxicol Appl Pharmacol; 2013 Jul; 270(2):114-21. PubMed ID: 23602888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1.
    Zhang Z; Lu H; Huan F; Meghan C; Yang X; Wang Y; Wang X; Wang X; Wang SL
    Int J Cancer; 2014 Apr; 134(7):1539-48. PubMed ID: 24114584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA: substrate specificity with model substrates and promutagens.
    Penman BW; Chen L; Gelboin HV; Gonzalez FJ; Crespi CL
    Carcinogenesis; 1994 Sep; 15(9):1931-7. PubMed ID: 7923587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aflatoxin B1 alters the expression of p53 in cytochrome P450-expressing human lung cells.
    Van Vleet TR; Watterson TL; Klein PJ; Coulombe RA
    Toxicol Sci; 2006 Feb; 89(2):399-407. PubMed ID: 16280384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of aflatoxin B1 by normal human bronchial epithelial cells.
    Van Vleet TR; Klein PJ; Coulombe RA
    J Toxicol Environ Health A; 2001 Aug; 63(7):525-40. PubMed ID: 11497333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of a HepG2 cell line stably expressing human cytochrome P450 1A2 and its metabolic activity].
    Zhu-Ge J; Ye S; Yu YN
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 32(5):403-6. PubMed ID: 14610739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
    Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
    Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic drug metabolism: studies with recombinant Chinese hamster cells and analyses in human populations.
    Yokoi T; Sawada M; Kamataki T
    Pharmacogenetics; 1995; 5 Spec No():S65-9. PubMed ID: 7581492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3.
    Crespi CL; Penman BW; Steimel DT; Gelboin HV; Gonzalez FJ
    Carcinogenesis; 1991 Feb; 12(2):355-9. PubMed ID: 1899812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells.
    Yang XJ; Lu HY; Li ZY; Bian Q; Qiu LL; Li Z; Liu Q; Li J; Wang X; Wang SL
    Toxicology; 2012 Oct; 300(3):138-48. PubMed ID: 22743290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM; Bammler TK; Hayes JD; Eaton DL
    Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
    Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
    Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editor's Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver.
    Sriwattanapong K; Slocum SL; Chawanthayatham S; Fedeles BI; Egner PA; Groopman JD; Satayavivad J; Croy RG; Essigmann JM
    Toxicol Sci; 2017 Nov; 160(1):173-179. PubMed ID: 28973694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae.
    Fasullo M; Smith A; Egner P; Cera C
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Feb; 761():18-26. PubMed ID: 24472830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose microcystin-LR antagonizes aflatoxin B1 induced hepatocarcinogenesis through decreasing cytochrome P450 1A2 expression and aflatoxin B1-DNA adduct generation.
    Wang L; He L; Zeng H; Fu W; Wang J; Tan Y; Zheng C; Qiu Z; Luo J; Lv C; Huang Y; Shu W
    Chemosphere; 2020 Jun; 248():126036. PubMed ID: 32045972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.